Comment l'âge affecte-t-il le risque de vasoconstriction ?
Le risque de vasoconstriction augmente avec l'âge en raison de la rigidité des vaisseaux sanguins.
VasoconstrictionÂgeRigidité vasculaire
#5
Quels médicaments peuvent augmenter le risque de vasoconstriction ?
Certains médicaments comme les décongestionnants peuvent provoquer une vasoconstriction.
VasoconstrictionMédicamentsDécongestionnants
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vasoconstricteurs : Questions médicales les plus fréquentes",
"headline": "Vasoconstricteurs : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vasoconstricteurs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-20",
"dateModified": "2026-06-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vasoconstricteurs"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agents cardiovasculaires",
"url": "https://questionsmedicales.fr/mesh/D002317",
"about": {
"@type": "MedicalCondition",
"name": "Agents cardiovasculaires",
"code": {
"@type": "MedicalCode",
"code": "D002317",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.411"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agonistes des canaux calciques",
"alternateName": "Calcium Channel Agonists",
"url": "https://questionsmedicales.fr/mesh/D002120",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des canaux calciques",
"code": {
"@type": "MedicalCode",
"code": "D002120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.411.793.205"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vasoconstricteurs",
"alternateName": "Vasoconstrictor Agents",
"code": {
"@type": "MedicalCode",
"code": "D014662",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Simin Yan",
"url": "https://questionsmedicales.fr/author/Simin%20Yan",
"affiliation": {
"@type": "Organization",
"name": "Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA."
}
},
{
"@type": "Person",
"name": "Thomas C Resta",
"url": "https://questionsmedicales.fr/author/Thomas%20C%20Resta",
"affiliation": {
"@type": "Organization",
"name": "Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA."
}
},
{
"@type": "Person",
"name": "Nikki L Jernigan",
"url": "https://questionsmedicales.fr/author/Nikki%20L%20Jernigan",
"affiliation": {
"@type": "Organization",
"name": "Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA."
}
},
{
"@type": "Person",
"name": "Tingting Guo",
"url": "https://questionsmedicales.fr/author/Tingting%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Cardiovascular Research Center, Shantou University Medical College, Shantou, China."
}
},
{
"@type": "Person",
"name": "Bin Liu",
"url": "https://questionsmedicales.fr/author/Bin%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Cardiovascular Research Center, Shantou University Medical College, Shantou, China; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou, China. Electronic address: bliu@stu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.",
"datePublished": "2024-08-16",
"url": "https://questionsmedicales.fr/article/39286706",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.67034"
}
},
{
"@type": "ScholarlyArticle",
"name": "Responses to Valsalva's maneuver in spinal cord injury do not broadly relate to vasoconstrictor capacity.",
"datePublished": "2024-09-19",
"url": "https://questionsmedicales.fr/article/39300002",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10286-024-01060-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vasoconstrictor Effects of Trace Amine Associated Receptor Agonists in the Isolated Perfused Rat Kidney.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39047696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000540429"
}
},
{
"@type": "ScholarlyArticle",
"name": "A comparative review of epinephrine and phenylephrine as vasoconstrictors in dental anesthesia: exploring the factors behind epinephrine's prevalence in the US.",
"datePublished": "2023-11-27",
"url": "https://questionsmedicales.fr/article/38076507",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17245/jdapm.2023.23.6.293"
}
},
{
"@type": "ScholarlyArticle",
"name": "The use of peripheral vasopressors and its implications for hospital medicine.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39078910",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12968/hmed.2024.0048"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002317"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vasoconstricteurs",
"item": "https://questionsmedicales.fr/mesh/D014662"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vasoconstricteurs - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vasoconstricteurs",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vasoconstricteurs",
"description": "Comment diagnostiquer une vasoconstriction excessive ?\nQuels tests sont utilisés pour évaluer la circulation sanguine ?\nQuels symptômes indiquent une vasoconstriction ?\nComment évaluer l'effet des vasoconstricteurs ?\nQuels examens sont nécessaires pour une vasoconstriction chronique ?",
"url": "https://questionsmedicales.fr/mesh/D014662#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vasoconstricteurs",
"description": "Quels sont les symptômes d'une vasoconstriction aiguë ?\nComment reconnaître une vasoconstriction périphérique ?\nQuels signes cliniques sont associés à une vasoconstriction ?\nQuels symptômes peuvent indiquer une réaction aux vasoconstricteurs ?\nQuels symptômes sont liés à une vasoconstriction prolongée ?",
"url": "https://questionsmedicales.fr/mesh/D014662#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vasoconstricteurs",
"description": "Comment prévenir la vasoconstriction liée au stress ?\nQuels changements de mode de vie aident à prévenir la vasoconstriction ?\nComment éviter la vasoconstriction due au tabagisme ?\nQuels aliments peuvent aider à prévenir la vasoconstriction ?\nComment la gestion de la pression artérielle aide-t-elle à prévenir la vasoconstriction ?",
"url": "https://questionsmedicales.fr/mesh/D014662#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vasoconstricteurs",
"description": "Quels traitements sont disponibles pour la vasoconstriction ?\nComment les vasoconstricteurs sont-ils administrés ?\nQuels médicaments sont considérés comme vasoconstricteurs ?\nComment traiter une vasoconstriction due à un choc ?\nQuels sont les effets des vasodilatateurs sur la vasoconstriction ?",
"url": "https://questionsmedicales.fr/mesh/D014662#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vasoconstricteurs",
"description": "Quelles complications peuvent résulter d'une vasoconstriction prolongée ?\nComment la vasoconstriction affecte-t-elle le cœur ?\nQuels risques sont associés à l'utilisation excessive de vasoconstricteurs ?\nQuelles sont les conséquences d'une vasoconstriction cérébrale ?\nComment la vasoconstriction peut-elle affecter les membres ?",
"url": "https://questionsmedicales.fr/mesh/D014662#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vasoconstricteurs",
"description": "Quels facteurs de risque sont associés à la vasoconstriction ?\nComment le diabète influence-t-il la vasoconstriction ?\nQuel rôle joue l'hérédité dans la vasoconstriction ?\nComment l'âge affecte-t-il le risque de vasoconstriction ?\nQuels médicaments peuvent augmenter le risque de vasoconstriction ?",
"url": "https://questionsmedicales.fr/mesh/D014662#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une vasoconstriction excessive ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests de pression artérielle et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la circulation sanguine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests Doppler et les angiographies sont couramment utilisés pour évaluer la circulation."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une vasoconstriction ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des engourdissements ou des changements de couleur de la peau peuvent indiquer une vasoconstriction."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'effet des vasoconstricteurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation peut se faire par la mesure de la pression artérielle et des signes cliniques."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour une vasoconstriction chronique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie peuvent être nécessaires pour une évaluation complète."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une vasoconstriction aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs thoraciques, des palpitations et des engourdissements."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une vasoconstriction périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des extrémités froides, une peau pâle et des douleurs peuvent indiquer une vasoconstriction périphérique."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une vasoconstriction ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une pression artérielle élevée et des changements de couleur de la peau."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une réaction aux vasoconstricteurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête, des nausées et des palpitations peuvent survenir après l'utilisation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une vasoconstriction prolongée ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une fatigue, des douleurs chroniques et des troubles circulatoires peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment prévenir la vasoconstriction liée au stress ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress comme la méditation et l'exercice peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels changements de mode de vie aident à prévenir la vasoconstriction ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et l'hydratation sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Comment éviter la vasoconstriction due au tabagisme ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser de fumer et éviter les environnements enfumés peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels aliments peuvent aider à prévenir la vasoconstriction ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les aliments riches en oméga-3, comme le poisson, peuvent aider à améliorer la circulation."
}
},
{
"@type": "Question",
"name": "Comment la gestion de la pression artérielle aide-t-elle à prévenir la vasoconstriction ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une pression artérielle normale réduit le risque de vasoconstriction et de complications."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la vasoconstriction ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments vasodilatateurs et des modifications du mode de vie."
}
},
{
"@type": "Question",
"name": "Comment les vasoconstricteurs sont-ils administrés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie intraveineuse, orale ou par inhalation selon le besoin."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont considérés comme vasoconstricteurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme la noradrénaline et la phényléphrine sont des vasoconstricteurs courants."
}
},
{
"@type": "Question",
"name": "Comment traiter une vasoconstriction due à un choc ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des vasopresseurs et des fluides intraveineux pour stabiliser le patient."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des vasodilatateurs sur la vasoconstriction ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vasodilatateurs aident à réduire la pression artérielle et à améliorer le flux sanguin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une vasoconstriction prolongée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'hypertension, les maladies cardiaques et les troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Comment la vasoconstriction affecte-t-elle le cœur ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut augmenter la charge de travail du cœur, entraînant des problèmes cardiaques potentiels."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'utilisation excessive de vasoconstricteurs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation excessive peut entraîner des arythmies, une hypertension et des lésions tissulaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une vasoconstriction cérébrale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des maux de tête, des vertiges et, dans les cas graves, un AVC."
}
},
{
"@type": "Question",
"name": "Comment la vasoconstriction peut-elle affecter les membres ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs, des engourdissements et, dans les cas extrêmes, des nécroses."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à la vasoconstriction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'obésité, le stress et une alimentation riche en sel."
}
},
{
"@type": "Question",
"name": "Comment le diabète influence-t-il la vasoconstriction ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète peut endommager les vaisseaux sanguins, augmentant le risque de vasoconstriction."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hérédité dans la vasoconstriction ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque de vasoconstriction."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le risque de vasoconstriction ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de vasoconstriction augmente avec l'âge en raison de la rigidité des vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent augmenter le risque de vasoconstriction ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments comme les décongestionnants peuvent provoquer une vasoconstriction."
}
}
]
}
]
}
Cardiovascular Research Center, Shantou University Medical College, Shantou, China; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou, China. Electronic address: bliu@stu.edu.cn.
Cardiovascular Research Center, Shantou University Medical College, Shantou, China; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou, China.
Division of Kinesiology, School of Health and Human Performance, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: myles.obrien@dal.ca.
Hepatorenal syndrome (HRS) is an acute complication of advanced liver disease, which manifests with a rapidly progressive decline in kidney function. Though pharmacological treatment has been recently...
A blood pressure stabilization during late phase II of Valsalva's maneuver may be utilized to confirm sympathetic vasoconstrictor control after a spinal cord injury. This study investigated whether Va...
Presence/absence of Valsalva response was compared to heart rate, mean arterial pressure, leg blood flow, and vascular resistance during head-up tilt and isometric handgrip to fatigue in 14 adults wit...
In total, six participants with spinal cord injury lacked a blood pressure stabilization for Valsalva's maneuver. However, this was not related to vasoconstrictor responses during the other tests. The...
Valsalva response was not consistent with hemodynamics during other stimuli, but some individuals evidence increases in sub-lesional vascular resistance to isometric handgrip comparable to controls, s...
Endogenous trace amines such as tryptamine and 3-iodothyronamine (T1AM) are present in mammalian tissues at very low concentrations. They produce their actions by activating surface G protein-coupled ...
The study was designed to investigate the possible vasoconstrictor effects of tryptamine, T1AM, and the selective TAAR1 agonist RO5263397 in isolated perfused rat kidney....
Renal vascular reactivity experiment using Male Wistar Kyoto (WKY, n = 82) and Spontaneously Hypertensive Rats (SHR, n = 89) were used in this study....
Tryptamine, T1AM, and RO5263397 increased perfusion pressure in preparations from WKY rats and SHRs in a dose-dependent manner, with no significant difference between the agonist's pD2 values (P > ...
The agonist-induced increase in perfusion pressure in the kidney involves the influx of extracellular calcium, increased calcium sensitization, and ROS in SHRs only....
This review paper delves into the comparative study of epinephrine and phenylephrine as vasoconstrictors in dental anesthesia, exploring their histories, pharmacological properties, and clinical appli...
Vasopressor medications for circulatory shock have historically been administered through central venous catheters due to concern for extravasation injury when given peripherally. However, recent stud...
The combination of local anesthetic drugs with epinephrine has conventionally been contraindicated in acral regions due to concerns of potential necrosis caused by compromised blood flow. However, thi...
There exists limited agreement on the recommendations for the treatment of transitional circulatory instability (TCI) in preterm neonates OBJECTIVE: To compare the efficacy of various interventions us...
Dopamine, dobutamine, epinephrine, hydrocortisone, vasopressin, milrinone, volume and placebo....
Mortality, major brain injury (MBI) (intraventricular haemorrhage > grade 2 or cystic periventricular leukomalacia), necrotising enterocolitis (NEC) ≥stage 2 and treatment response (as defined by the ...
15 Randomized Controlled Trials (RCTs) were included from the 1365 titles and abstracts screened. Clinical benefit or harm could not be ruled out for the critical outcome of mortality. For the outcome...
Epinephrine may be used as the first-line drug in preterm neonates with TCI, the evidence certainty being very low. We suggest future trials evaluating the management of TCI with an emphasis on object...
Background : The influence of restrictive fluid resuscitation and the early administration of vasopressors on the clinical outcomes in patients with septic shock are not fully understood. The purpose ...
Differential activation of the renin-angiotensin system (RAS) likely contributes to sex differences in cardiovascular outcomes in premenopausal women compared with age-matched men. Women demonstrate r...
Hepatorenal syndrome (HRS), a special form of acute kidney failure, is a rare, acute, life-threatening complication of cirrhosis and has a very poor prognosis. Terlipressin (TERLIVAZ...
A decision analytic model was developed to estimate the HRS treatment-related cost per response over an HRS hospitalization (assuming 14 days). Patients can experience either HRS reversal (complete re...
Cost per response of terlipressin + albumin was lower than midodrine and octreotide + albumin (M&O) (US$85,315 vs. $467,794) and norepinephrine + albumin ($81,614 vs. $139,324). NNT for HRS reversal w...
The analysis shows that terlipressin is a cost-effective treatment due to its higher efficacy and administration in the non-ICU setting. Terlipressin is a value-based treatment option for appropriate ...